Transitioning to serum-free T cell manufacturing: process considerations and cross-platform scale-up data
Serum is one of the largest sources of variability in T cell manufacturing, driving lot-to-lot inconsistency, sourcing constraints, and contamination risk. This data-led session shows you how a chemically defined, serum-free workflow removes that dependency, so you can build more reproducible processes from early development through clinical scale. Chengkang Zhang will walk through experimental data on the impact of serum…